Streetbeat News

Analyst Ratings

PCAR

B of A Securities analyst Ross Gilardi has upgraded PACCAR (NASDAQ:PCAR) from Underperform to Neutral and increased the price target from $84 to $97.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:22 pm

IKNA

HC Wainwright & Co. analyst Andres Maldonado has reiterated a Buy rating on Ikena Oncology (NASDAQ:IKNA) and maintained a price target of $11. This reaffirmation of the stock's potential could influence investor sentiment and the stock's short-term performance.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:16 pm

ONCY

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Oncolytics Biotech (NASDAQ:ONCY) and maintained a price target of $5. The reaffirmation of the Buy rating and price target suggests a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:02 pm

ACCD

Accolade (NASDAQ:ACCD) has received mixed ratings from 7 analysts over the last quarter, with recent sentiment showing 1 bullish rating in the last 30 days compared to 2 bullish and 2 somewhat bullish ratings 1 month ago. The 12-month price target average has increased to $14.71, up 8.96% from the previous $13.50, with a high estimate of $17.00 and a low of $12.00. Analysts from firms including Needham, Truist Securities, Piper Sandler, Wells Fargo, Raymond James, and Stifel have updated their ratings and price targets, reflecting their views on Accolade's market performance and financials. Accolade's financial indicators show a positive revenue trend with a growth rate of 9.26% as of November 30, 2023, but it has a net margin of -21.2% and ROE of -4.83%, indicating potential profitability and efficiency challenges.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 12:01 pm

DKNG

In the past three months, 17 analysts have provided ratings for DraftKings (NASDAQ:DKNG), with a majority being bullish. The average 12-month price target is now $44.76, up from $40.00, with high and low estimates of $50.00 and $28.00 respectively. Analysts have adjusted their ratings and price targets, reflecting their latest views on the company's performance and market conditions. DraftKings has shown significant revenue growth but struggles with profitability, as indicated by a net margin of -35.84% and an ROE of -31.11%. The company is active in online sports betting, iGaming, and operates an NFT marketplace.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 12:00 pm

OLED

Analyst ratings for Universal Display (NASDAQ:OLED) show varied opinions, with recent updates indicating both upgrades and a downgrade. The average 12-month price target is $204.00, up from $174.25. The company faces revenue challenges with a -12.13% decline over 3 months but maintains a high net margin of 36.34%. Its market capitalization is below industry benchmarks, and it has a low debt-to-equity ratio of 0.02. Analysts' actions and price target adjustments reflect their views on the company's performance and market conditions.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 12:00 pm

EE

Analysts have mixed opinions on Excelerate Energy (NYSE:EE), with recent ratings ranging from bullish to bearish. Over the last quarter, 6 analysts provided ratings, with 4 somewhat bullish and 2 indifferent. The average 12-month price target is $23.67, down 7.18% from previous estimates. Key analysts from firms like Raymond James, Wells Fargo, Capital One, and Morgan Stanley have adjusted their ratings and price targets. Excelerate Energy's financial health shows a negative revenue trend with a -65.71% decline over 3 months, a net margin of 5.04%, an ROE of 2.8%, an ROA of 0.48%, and a debt-to-equity ratio of 1.69.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 12:00 pm

JELD

Six analysts have recently updated their ratings on JELD-WEN Holding (NYSE:JELD), with all maintaining a neutral stance. The average 12-month price target for JELD-WEN has been raised to $17.67, a 10.99% increase from the previous target of $15.92. Analysts from firms including Stifel, Goldman Sachs, Barclays, JP Morgan, and Truist Securities have all raised their price targets. JELD-WEN operates in door and window manufacturing and has shown strong profitability with a net margin of 4.07% and an ROE of 5.41%, but faces challenges with a revenue decline of -5.53% and a high debt-to-equity ratio of 1.63.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 12:00 pm

AVGO

Broadcom (NASDAQ:AVGO) received mixed analyst ratings in the latest quarter, with 9 analysts offering opinions. The average 12-month price target for AVGO is $1111.11, a 13.09% increase from the previous target of $982.50. Notable analysts from firms like Goldman Sachs, Citigroup, and Truist Securities have provided ratings ranging from 'Buy' to 'Market Perform' with various price targets. Broadcom is a major semiconductor and software company with over $30 billion in annual revenue. It has shown a revenue growth rate of 4.09% and a high net margin of 37.91%. However, its debt-to-equity ratio of 1.64 indicates a higher financial risk.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 12:00 pm

SGMO

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Sangamo Therapeutics (NASDAQ:SGMO) and maintained a price target of $3. This reaffirmation of the company's stock rating and price target suggests continued confidence in Sangamo's prospects.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 11:59 am